OA09.01 First-line Nivolumab + Ipilimumab + Chemo in Patients With Advanced NSCLC and Brain Metastases: Results From CheckMate 9LA
David P. Carbone, Tudor–Eliade Ciuleanu, Manuel Cobo, Michael Schenker, Bogdan Żurawski, J. Menezes, Eduardo Richardet, Jaafar Bennouna, Enriqueta Felip, Óscar Juan, Aurelia Alexandru, Hiroshi Sakai, Emmanuel de la Mora Jimenez, L. Paz-Ares, Martin Reck, Thomas John, Nan Hu, X. Zhang, Phuong Tran, Diederik J. Grootendorst, Shun Lü
Topics & Concepts
MedicineNivolumabIpilimumabOncologyInternal medicineClinical endpointLung cancerOverall survivalBrain metastasisClinical trialCancerImmunotherapyMetastasisBrain Metastases and TreatmentLung Cancer Treatments and MutationsLung Cancer Research Studies